He reported Q2 revenues of $120 million, a 1.6% decline year-over-year, but sequential growth of just over 15.5% on Q1, with adjusted EBITDA at $17 million. A net loss of $399 million was attributed ...

Stock index futures were up on Tuesday, as investors braced for the July retail inflation data set to come before the market ...

The US Treasury recently announced that it will need to borrow far more than expected, now over $1T for Q3 2025. Read the ...

Rocket Lab (RKLB) acquires Geost to enhance U.S. defense projects with advanced EO/IR technologies, bolstering capabilities ...

According to the CME FedWatch tool, the odds of a September rate cut have ticked up to about 94% from around 86% the previous ...

Archer Aviation's Q2 report showcases progress toward revenue, a $1.7B cash runway, and growth potential. Check out why I ...

Strategic focus continues to be on Anaphylm’s FDA approval, commercial launch, and financing. Management reiterated international expansion plans for Anaphylm, whereas the previous quarter emphasized ...

Discover key insights from Hydrofarm's Q2 2025 earnings call: restructuring for $3M+ savings, stronger margins, and focus on proprietary, noncannabis growth.

President Donald Trump, who has long vented against Federal Reserve Chair Jerome Powell for not cutting rates, has found a ...

Discover Acurx Pharmaceuticals' Q2 2025 highlights: key patent milestones, Phase IIb trial success, cost controls, and funding strategies for Phase III.